Navigation Links
EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting
Date:5/19/2011

ROCKVILLE, Md., May 19, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the presentation of clinical data for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.  The data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held June 3 - 7, 2011 in Chicago, Illinois.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)-

Gynecologic Cancer Track: Poster SessionFriday, June 3, 2011 – 2:00 p.m. - 6:00 p.m. (CDT) Abstract No.: 5021Title: A Phase 2 Study of ENMD-2076 in platinum-resistant ovarian cancer Poster Board: 10, Location: E450aDiscussion SessionFriday, June 3, 2011 – 5:00 p.m. - 6:00 p.m. (CDT)Location: E354bAbout ENMD-2076ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. Preclinical studies with ENMD-2076 demonstrated significant antitumor activity, including tumor regression, in multiple solid and hematological malignancies. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. While ENMD-2076 is currently in a Phase 2 trial in ovarian cancer, preclinical and clinical activities are ongoing in assessing the compound's applicability in other forms of cancer.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... -- Chinese magnesium alloy maker DongGuan Eontec Co., Ltd ... bone fixation screw has received Chinese regulatory inspection approval ... and that the company acknowledges receipt of the approval ... and Technology Daily journalists Wang Xiangming and ... Professor Li Yangde , has been a pioneer ...
(Date:11/27/2014)... - New Solution That Makes JINS MEME,s Raw ... Ltd. will launch JINS MEME "ACADEMIC PACK" in late April, ... (without tax /including two pairs of JINS MEME and designated ... of "JINS MEME" to academic researchers, and it enables them ... and six-axis sensors without API. (*Physiological data that can be ...
(Date:11/26/2014)... Company plc ("Perrigo") (NYSE: PRGO ; TASE), ... today announced the closing of Perrigo,s previously announced registered ... shares at a public offering price of $152.00 per ... purchase up to an additional 888,157 ordinary shares by ... representatives of the several underwriters. Perrigo ...
Breaking Medicine Technology:Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4
... Texas, Nov. 18, 2010 OCuSOFT, Inc., an ... to announce that ZYTAZE™ is now available in ... but are not limited to: Walgreens, CVS, Wal-Mart, ... In an early pilot study, ZYTAZE™ demonstrated marked ...
... FORD, Pa., Nov. 18, 2010 Endo Pharmaceuticals Holdings ... it priced $400 million aggregate principal amount of 7.00% ... of 99.10 percent in connection with its previously announced ... of the Company and will be guaranteed by certain ...
Cached Medicine Technology:Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes 2
(Date:11/29/2014)... November 29, 2014 ... provides both qualitative and quantitative ... competitive strategies preferred by key ... boosted the growth, and restraints ... studies the opportunities in the ...
(Date:11/28/2014)... Lunadress.co.uk, one of the world’s leading suppliers of ... its fashionable white prom gowns. These new LunaDress ... price. The company provides a big discount of up ... for orders over 99 pounds. , LunaDress provides excellent ... if needed. The kind experts will explain the related ...
(Date:11/28/2014)... 29, 2014 Recently, BellasDress , a ... addition of a new line of cocktail dresses. In addition, ... to 80% off with free shipping on orders over $179. ... new season. , Bellasdress.com is providing many styles of dresses, ... dresses, little black dresses and more. All of them are ...
(Date:11/28/2014)... November 28, 2014 The clinic ... such as Dynamic Neuromuscular Stabilization, Extracorporeal Shock Wave ... After moving to upgraded facilities in 2011, the ... Now, owner Dr. Lev Kalika has launched the ... prevention lab in the country. , The new ...
(Date:11/28/2014)... Boston, MA (PRWEB) November 28, 2014 Agein.com, ... news, and advice from some of the foremost experts in ... tips for preventing dry skin this winter. , “The official ... of North America has already been hit with an icy ... year, many are wondering if 2015 will usher in another ...
Breaking Medicine News(10 mins):Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 2Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 3Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 4Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:BellasDress Offers A Big Surprise By Updating Its Cheap and Charming Cocktail Dresses 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3Health News:Agein Corporation, a Leading Anti-Aging Company, Releases Top Diet and Personal Care Tips for Preventing Dry Skin this Season 2
... HealthDay Reporter , WEDNESDAY, April 6 (HealthDay News) -- ... to mention the Grim Reaper, a new study from Taiwan ... shopping daily live longer than their less shopping-prone peers. ... according to the study, which was published recently in the ...
... that patients treated with a short course of antidepressants ... recovery than patients treated with a placebo. Moreover, the ... recovery continues to improve for at least nine months ... that antidepressants might benefit early recovery from stroke has ...
... anticipate more trips to the moon and manned missions ... Earth,s magnetic field could be detrimental to their arteries, ... Birmingham researchers published April 6, 2011, online in the ... model, researchers assessed the affect of iron ion radiation ...
... 7, 2011) -- Deep brain stimulation, a surgical procedure ... patients to stop the medications used to treat their ... of South Florida researchers report. "It,s a significant ... improvement with this treatment option," said Andrew Resnick, a ...
... The Endocrine Society released a new Clinical Practice Guideline (CPG) ... is published in the April 2011 issue of the ... of The Endocrine Society. A pituitary incidentaloma is a ... is found when a person has an imaging test for ...
... HealthDay Reporter , WEDNESDAY, April 6 (HealthDay News) ... acute respiratory distress syndrome (ARDS) remain physically and emotionally ... their lungs heal almost completely, a new study indicates. ... whom participated in a previous one-year study -- Canadian ...
Cached Medicine News:Health News:'Retail Therapy' Might Really Work 2Health News:'Retail Therapy' Might Really Work 3Health News:U. Iowa study suggests antidepressants aid physical recovery in stroke 2Health News:U. Iowa study suggests antidepressants aid physical recovery in stroke 3Health News:Deep-space travel could create heart woes for astronauts 2Health News:Deep-space travel could create heart woes for astronauts 3Health News:Most patients stop drugs for essential tremor after deep brain stimulation surgery 2Health News:Most patients stop drugs for essential tremor after deep brain stimulation surgery 3Health News:Experts issue recommendations for evaluating and treating pituitary incidentalomas 2Health News:Years Later, Victims of Critical Respiratory Illness Still Suffer 2Health News:Years Later, Victims of Critical Respiratory Illness Still Suffer 3
... Practice management software for eyecare ... true multi-tasking, multi-office practice management ... database technology- Winx Pro is ... assist you in effectively managing ...
... Working with over 2,500 ... proud to serve one ... client bases in the ... PM Ophthalmology, we are ...
... EMR Ophthalmology is a comprehensive electronic ... for ophthalmology practices. Intuition EMR Ophthalmology ... provides the tools to evaluate your ... to make better decisions and to ...
... in advanced cartridge mixing and delivery systems. ... mechanically injects all types of bone cement ... line-up includes a large selection of nozzles ... difficult to access areas. A new, anatomically ...
Medicine Products: